mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.6 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
cyanoquinoline 11 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |